Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Breast Cancer

Free Subscription 11.05.2020 2 AJR Am J Roentgenol 1 Am J Epidemiol 1 Am J Pathol 4 Anticancer Res 5 BMC Cancer 1 Br J Cancer 5 Breast Cancer 2 Breast Cancer Res 8 Breast Cancer Res Treat 3 Breast J 2 Cancer 2 Clin Breast Cancer 2 Eur J Surg Oncol 2 Eur Radiol 1 Exp Cell Res 1 Histopathology 2 Int J Cancer 1 Int J Oncol 1 J Clin Invest 1 J Clin Oncol 1 J Natl Cancer Inst 3 Lancet Oncol 1 Mod Pathol 1 Oncogene 7 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. MILON A, Wahab CA, Kermarrec E, Bekhouche A, et al
   Breast MRI: Is Faster Better?
   AJR Am J Roentgenol. 2019 Dec 11:1-14. doi: 10.2214/AJR.19.21924.
   PubMed         Abstract available
   
   
2. LEWIN AA, Mercado CL
   Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
   AJR Am J Roentgenol. 2020;214:265-275.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

3. FOERSTER M, Anele A, Adisa C, Galukande M, et al
   Few Losses to Follow-Up in a Sub-Saharan African Cancer Cohort via Active mHealth Follow-Up: the Prospective ABC-DO Breast Cancer Cohort.
   Am J Epidemiol. 2020 May 8. pii: 5834359. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Pathol

4. NELSON LJ, Wright HJ, Dinh NB, Nguyen KD, et al
   Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C delta Pathway in a Subset of Triple-Negative Breast Cancers.
   Am J Pathol. 2020;190:484-502.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. LIM HI, Yamamoto J, Inubushi S, Nishino H, et al
   A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
   Anticancer Res. 2020;40:2481-2485.
   PubMed         Abstract available
   
   
6. WATROWSKI R, Castillo-Tong DC, Obermayr E, Zeillinger R, et al
   Gene Expression of Kallikreins in Breast Cancer Cell Lines.
   Anticancer Res. 2020;40:2487-2495.
   PubMed         Abstract available
   
   
7. JUN S, Kim SW, Lim JY, Park SJ, et al
   ABHD12 Knockdown Suppresses Breast Cancer Cell Proliferation, Migration and Invasion.
   Anticancer Res. 2020;40:2601-2611.
   PubMed         Abstract available
   
   
8. DA SILVA A, Levy C, Allouache D, Hrab I, et al
   Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration.
   Anticancer Res. 2020;40:2955-2960.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. YOON SH, Kim HS, Kim RN, Jung SY, et al
   NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.
   BMC Cancer. 2020;20:375.
   PubMed         Abstract available
   
   
10. BJELIC-RADISIC V, Fitzal F, Knauer M, Steger G, et al
    Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
    BMC Cancer. 2020;20:392.
    PubMed         Abstract available
    
    
11. VAN DER MERWE NC, Oosthuizen J, Theron M, Chong G, et al
    The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
    BMC Cancer. 2020;20:391.
    PubMed         Abstract available
    
    
12. ADAMS EJ, Asad S, Reinbolt R, Collier KA, et al
    Metastatic breast cancer patient perceptions of somatic tumor genomic testing.
    BMC Cancer. 2020;20:389.
    PubMed         Abstract available
    
    
13. KIM SH, Choe YH, Han AR, Yeon GJ, et al
    Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors.
    BMC Cancer. 2020;20:367.
    PubMed         Abstract available
    
    

    
    Br J Cancer

14. EGGEMANN H, Brucker C, Schrauder M, Thill M, et al
    Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis.
    Br J Cancer. 2020 May 5. pii: 10.1038/s41416-020-0857.
    PubMed         Abstract available
    
    

    
    Breast Cancer

15. CHAO YH, Wang SY, Sheu SJ
    Integrative review of breast cancer survivors' transition experience and transitional care: dialog with transition theory perspectives.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01097.
    PubMed         Abstract available
    
    
16. KIM S, Lee S, Bae Y, Lee S, et al
    Nipple-sparing mastectomy for breast cancer close to the nipple: a single institution's 11-year experience.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01104.
    PubMed         Abstract available
    
    
17. YUEN S, Monzawa S, Yanai S, Matsumoto H, et al
    The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images.
    Breast Cancer. 2020 May 6. pii: 10.1007/s12282-020-01105.
    PubMed         Abstract available
    
    
18. XU Y, Zhang Z, Zhang L, Zhang C, et al
    Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis.
    Breast Cancer. 2020 May 1. pii: 10.1007/s12282-020-01101.
    PubMed         Abstract available
    
    
19. SEKINE H, Kijima Y, Kobayashi M, Itami J, et al
    Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients.
    Breast Cancer. 2020 May 3. pii: 10.1007/s12282-020-01082.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

20. PEREZ KERKVLIET C, Dwyer AR, Diep CH, Oakley RH, et al
    Glucocorticoid receptors are required effectors of TGFbeta1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
    Breast Cancer Res. 2020;22:39.
    PubMed         Abstract available
    
    
21. GOLE L, Yeong J, Lim JCT, Ong KH, et al
    Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients.
    Breast Cancer Res. 2020;22:42.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

22. STOVGAARD ES, Bokharaey M, List-Jensen K, Roslind A, et al
    PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies.
    Breast Cancer Res Treat. 2020 May 2. pii: 10.1007/s10549-020-05655.
    PubMed         Abstract available
    
    
23. WANG RX, Ji P, Gong Y, Shao ZM, et al
    Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.
    Breast Cancer Res Treat. 2020 May 2. pii: 10.1007/s10549-020-05660.
    PubMed         Abstract available
    
    
24. WANG C, Mu Z, Ye Z, Zhang Z, et al
    Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
    Breast Cancer Res Treat. 2020 May 4. pii: 10.1007/s10549-020-05662.
    PubMed         Abstract available
    
    
25. O'DONNELL PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, et al
    Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
    Breast Cancer Res Treat. 2020 May 6. pii: 10.1007/s10549-020-05603.
    PubMed         Abstract available
    
    
26. NINO DE GUZMAN E, Song Y, Alonso-Coello P, Canelo-Aybar C, et al
    Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic literature review.
    Breast Cancer Res Treat. 2020 May 6. pii: 10.1007/s10549-020-05657.
    PubMed         Abstract available
    
    
27. O'TOOLE SA, Spillane C, Huang Y, Fitzgerald MC, et al
    Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2020 May 6. pii: 10.1007/s10549-020-05658.
    PubMed         Abstract available
    
    
28. HEYDON-WHITE A, Suami H, Boyages J, Koelmeyer L, et al
    Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography.
    Breast Cancer Res Treat. 2020 May 6. pii: 10.1007/s10549-020-05661.
    PubMed         Abstract available
    
    
29. EDMAN KESSLER L, Sigfridsson J, Hatzidaki D, Bergh J, et al
    Chemotherapy use near the end-of-life in patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2020 May 7. pii: 10.1007/s10549-020-05663.
    PubMed         Abstract available
    
    

    
    Breast J

30. PETROU P
    A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13853.
    PubMed        
    
    
31. SALDI S, Perrucci E, Fulcheri CPL, Mariucci C, et al
    Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13855.
    PubMed        
    
    
32. TONELLOTTO F, Bergmann A, Abrahao KS, de Aguiar SS, et al
    Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13872.
    PubMed        
    
    

    
    Cancer

33. MA D, Jiang YZ, Xiao Y, Xie MD, et al
    Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
    Cancer. 2020 May 8. doi: 10.1002/cncr.32922.
    PubMed         Abstract available
    
    
34. BROWN LC, Murphy AR, Lalonde CS, Subhedar PD, et al
    Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function.
    Cancer. 2020 May 6. doi: 10.1002/cncr.32934.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

35. WANG K, Hackney JR, Siegal GP, Wei S, et al
    RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.
    Clin Breast Cancer. 2020 Apr 11. pii: S1526-8209(20)30071.
    PubMed         Abstract available
    
    
36. ZHOU SC, Le J, Zhou J, Huang YX, et al
    The Role of Contrast-Enhanced Ultrasound in the Diagnosis and Pathologic Response Prediction in Breast Cancer: A Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2020 Mar 20. pii: S1526-8209(20)30058.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

37. VICINI E, Galimberti V, Naninato P, Anna Rita AR, et al
    COVID-19: The European institute of oncology as a "hub" centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month.
    Eur J Surg Oncol. 2020 Apr 24. pii: S0748-7983(20)30423.
    PubMed        
    
    
38. TASOULIS MK, Roche N, MacNeill F
    Rationalizing breast cancer surgery during the COVID-19 pandemic.
    Eur J Surg Oncol. 2020 Apr 29. pii: S0748-7983(20)30446.
    PubMed        
    
    

    
    Eur Radiol

39. ABDOLELL M, Payne JI, Caines J, Tsuruda K, et al
    Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Eur Radiol. 2020 May 1. pii: 10.1007/s00330-020-06901.
    PubMed         Abstract available
    
    
40. WANG J, Phi XA, Greuter MJW, Daszczuk AM, et al
    The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
    Eur Radiol. 2020 May 7. pii: 10.1007/s00330-020-06812.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

41. CHEN Y, Du M, Yusuying S, Liu W, et al
    Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27(Kip1).
    Exp Cell Res. 2020 Apr 30:112038. doi: 10.1016/j.yexcr.2020.112038.
    PubMed         Abstract available
    
    

    
    Histopathology

42. ALTHOBITI M, El Ansari R, Aleskandarany M, Joseph C, et al
    The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Histopathology. 2020 May 5. doi: 10.1111/his.14129.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. HILBERS FS, van 't Hof PJ, Meijers CM, Mei H, et al
    Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.
    Int J Cancer. 2020 May 7. doi: 10.1002/ijc.33039.
    PubMed         Abstract available
    
    
44. SANDSVEDEN M, Nilsssson E, Borgquist S, Rosendahl AH, et al
    Pre-diagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics.
    Int J Cancer. 2020 May 6. doi: 10.1002/ijc.33031.
    PubMed         Abstract available
    
    

    
    Int J Oncol

45. CHEN F, Zhang Z, Yu Y, Liu Q, et al
    HSulf1 and palbociclib exert synergistic antitumor effects on RBpositive triplenegative breast cancer.
    Int J Oncol. 2020 May 4. doi: 10.3892/ijo.2020.5057.
    PubMed         Abstract available
    
    

    
    J Clin Invest

46. ZARRIZI R, Higgs MR, Vossgrone K, Rossing M, et al
    Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability.
    J Clin Invest. 2020 May 7. pii: 127521. doi: 10.1172/JCI127521.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

47. HERSHMAN DL, Unger JM, Hillyer GC, Moseley A, et al
    Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
    J Clin Oncol. 2020 May 5:JCO1902699. doi: 10.1200/JCO.19.02699.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

48. KAPOOR PM, Mavaddat N, Choudhury PP, Wilcox AN, et al
    Combined associations of a polygenic risk score and classical risk factors with breast cancer risk.
    J Natl Cancer Inst. 2020 May 2. pii: 5828224. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

49. DEKKER TJA
    Fulvestrant plus capivasertib for metastatic breast cancer.
    Lancet Oncol. 2020;21:e232.
    PubMed        
    
    
50. JONES RH, Casbard A, Carucci M, Foxley A, et al
    Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply.
    Lancet Oncol. 2020;21:e234.
    PubMed        
    
    
51. LUDMIR EB, McCaw ZR, Kim DH, Tian L, et al
    Fulvestrant plus capivasertib for metastatic breast cancer.
    Lancet Oncol. 2020;21:e233.
    PubMed        
    
    

    
    Mod Pathol

52. FARSHID G, Dhatrak D, Gilhotra A, Koszyca B, et al
    The impact of 2018 ASCO-CAP HER2 testing guidelines on breast cancer HER2 results. An audit of 2132 consecutive cases evaluated by immunohistochemistry and in situ hybridization.
    Mod Pathol. 2020 May 4. pii: 10.1038/s41379-020-0555.
    PubMed         Abstract available
    
    

    
    Oncogene

53. YONEDA A, Minomi K, Tamura Y
    HSP47 promotes metastasis of breast cancer by interacting with myosin IIA via the unfolded protein response transducer IRE1alpha.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1311.
    PubMed         Abstract available
    
    

    
    PLoS One

54. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    PubMed         Abstract available
    
    
55. LI X, Shen X, Zhou Y, Wang X, et al
    Classification of breast cancer histopathological images using interleaved DenseNet with SENet (IDSNet).
    PLoS One. 2020;15:e0232127.
    PubMed         Abstract available
    
    
56. LEE KN, Torres MA, Troeschel AN, He J, et al
    Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    PLoS One. 2020;15:e0232581.
    PubMed         Abstract available
    
    
57. RINALDI J, Sokol ES, Hartmaier RJ, Trabucco SE, et al
    The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
    PLoS One. 2020;15:e0231999.
    PubMed         Abstract available
    
    
58. HADGU E, Seifu D, Tigneh W, Bokretsion Y, et al
    Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0232519.
    PubMed         Abstract available
    
    
59. LI M, Yue C, Zuo X, Jin G, et al
    The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province.
    PLoS One. 2020;15:e0232174.
    PubMed         Abstract available
    
    
60. GARCIA-VAZQUEZ V, Calvo FA, Ledesma-Carbayo MJ, Sole CV, et al
    Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations.
    PLoS One. 2020;15:e0227155.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: